(a) For purposes of this section:(1) “oxybenzone” means the chemical (2-Hyroxy-4-methoxyphenyl)-phenylmethanone under the International Union of Pure and Applied Chemistry Chemical Nomenclature Registry, that has a Chemical Abstract Service Registry Number 131-57-7, and whose synonyms include benzophenone-3, Escalol 567, Eusolex 4360, KAHSCREEN BP-3, 4-methoxy-2-hydroxybenzophenone and Milestab 9, and is intended to be used as protection against ultraviolet light radiation with a spectrum wavelength from 400 nanometers to 280 nanometers in an epidermal sunscreen-protection.(2) “octinoxate” means the chemical ((RS)-2-Ethylhexyl(2E)-3-(4-methoxyphenyl)) prop-2-enoate under the International Union of Pure and Applied Chemistry Chemical Nomenclature Registry, that has a Chemical Abstract Service Registry Number 5466-77-3, and whose synonyms include ethylhexyl methoxycinnamate, octyl methoxycinnamate, Eusolex 2292, NSC 26466, Parsol MOX, Parsol MCX and Uvinul MC80, and is intended to be used as protection against ultraviolet light radiation with a spectrum wavelength from 400 nanometers to 280 nanometers in an epidermal sunscreen-protection.(3) “Octocrylene” means the chemical 2-ethylhexyl 2-cyano-3,3-diphenyl-2-propenoate under the International Union of Pure and Applied Chemistry Chemical Nomenclature Registry, that has a Chemical Abstract Service Registry Number 6197-30-4, and whose synonyms include octocrylene, octocrylene, Uvinul N-539, 2-ethulhezyl 2-cyano-3-3-diphenylacrylate, Octocrileno, Parasol 340, UV Absorber-3, Escalol 597, Eusolex OCR, Neo Heliopan 303, Sanduvor 3039, Seesorb 502, and Viosorb 930, and is intended to be used as protection against ultraviolet light radiation with a maximum ultraviolet spectrum wavelength at 303 nanometers in an epidermal sunscreen-protection.(4) “Prescription” means an order for medication that is dispensed to or for an ultimate user. Prescription does not include an order for medication that is dispensed for immediate administration to the ultimate user, such as a chart order to dispense a drug to a bed patient for immediate administration in hospital but includes an order for sunscreen.(5) “Sunscreen” means a product marketed or intended for topical use to prevent sunburn. Sunscreen does not include products marketed or intended for use as a cosmetic, as defined in section 301(i) of the Federal Food, Drug & Cosmetic Act, title 21, chapter 9, subchapter II of the United States Code, for use on the face.
(1) “oxybenzone” means the chemical (2-Hyroxy-4-methoxyphenyl)-phenylmethanone under the International Union of Pure and Applied Chemistry Chemical Nomenclature Registry, that has a Chemical Abstract Service Registry Number 131-57-7, and whose synonyms include benzophenone-3, Escalol 567, Eusolex 4360, KAHSCREEN BP-3, 4-methoxy-2-hydroxybenzophenone and Milestab 9, and is intended to be used as protection against ultraviolet light radiation with a spectrum wavelength from 400 nanometers to 280 nanometers in an epidermal sunscreen-protection.
(2) “octinoxate” means the chemical ((RS)-2-Ethylhexyl(2E)-3-(4-methoxyphenyl)) prop-2-enoate under the International Union of Pure and Applied Chemistry Chemical Nomenclature Registry, that has a Chemical Abstract Service Registry Number 5466-77-3, and whose synonyms include ethylhexyl methoxycinnamate, octyl methoxycinnamate, Eusolex 2292, NSC 26466, Parsol MOX, Parsol MCX and Uvinul MC80, and is intended to be used as protection against ultraviolet light radiation with a spectrum wavelength from 400 nanometers to 280 nanometers in an epidermal sunscreen-protection.
(3) “Octocrylene” means the chemical 2-ethylhexyl 2-cyano-3,3-diphenyl-2-propenoate under the International Union of Pure and Applied Chemistry Chemical Nomenclature Registry, that has a Chemical Abstract Service Registry Number 6197-30-4, and whose synonyms include octocrylene, octocrylene, Uvinul N-539, 2-ethulhezyl 2-cyano-3-3-diphenylacrylate, Octocrileno, Parasol 340, UV Absorber-3, Escalol 597, Eusolex OCR, Neo Heliopan 303, Sanduvor 3039, Seesorb 502, and Viosorb 930, and is intended to be used as protection against ultraviolet light radiation with a maximum ultraviolet spectrum wavelength at 303 nanometers in an epidermal sunscreen-protection.
(4) “Prescription” means an order for medication that is dispensed to or for an ultimate user. Prescription does not include an order for medication that is dispensed for immediate administration to the ultimate user, such as a chart order to dispense a drug to a bed patient for immediate administration in hospital but includes an order for sunscreen.
(5) “Sunscreen” means a product marketed or intended for topical use to prevent sunburn. Sunscreen does not include products marketed or intended for use as a cosmetic, as defined in section 301(i) of the Federal Food, Drug & Cosmetic Act, title 21, chapter 9, subchapter II of the United States Code, for use on the face.
(b) Unless prescribed by a licensed healthcare provider and imported, distributed and offered for sale by a licensed pharmacy or drug store as defined in 27 V.I.C. § 141, it is unlawful to:(1) sell, offer for sale, or distribute, after March 30, 2020, in the Virgin Islands any sunscreen product that contains oxybenzone, octocrylene or octinoxate including, but not limited to, lotions, pastes, balms, serums, or ointments;(2) import, after September 30, 2019, into the Virgin Islands for sale any sunscreen product that contains oxybenzone, octocrylene or octinoxate including, but not limited to, lotions, pastes, balms, serums, or ointments; or(3) use or possess, after March 30, 2020, while in the Virgin Islands, any sunscreen products that contains oxybenzone, octocrylene or octinoxate including, but not limited to, lotions, pastes, balms, serums, or ointments.
(1) sell, offer for sale, or distribute, after March 30, 2020, in the Virgin Islands any sunscreen product that contains oxybenzone, octocrylene or octinoxate including, but not limited to, lotions, pastes, balms, serums, or ointments;
(2) import, after September 30, 2019, into the Virgin Islands for sale any sunscreen product that contains oxybenzone, octocrylene or octinoxate including, but not limited to, lotions, pastes, balms, serums, or ointments; or
(3) use or possess, after March 30, 2020, while in the Virgin Islands, any sunscreen products that contains oxybenzone, octocrylene or octinoxate including, but not limited to, lotions, pastes, balms, serums, or ointments.
(c) After notice and an opportunity to be heard, the Department of Licensing and Consumer Affairs shall fine any person or entity found to have violated subsection (a), (b), or (c) of this section $1,000 for the first offense and $2,000 for each subsequent offense.